Table 3 Access to SRH self-care interventions among GVPS participants in the EMR
Self-care intervention | Access: places | Access: informational sources | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacy n (%) | Doctor or health clinic n (%) | Would buy it online n (%) | I don’t know where to get it n (%) | I don’t need to use this (not relevant) n (%) | Total respondents n | I go online / internet n (%) | I ask my friends and community n (%) | I ask a doctor or health care provider n (%) | I haven’t gotten any information on this n (%) | Total respondents n | |
Reproductive health | |||||||||||
Oral contraceptive pill | 19 (50.0) | 18 (47.4) | 0 (0.0) | 0 (0.0) | 9 (23.7) | 38 | 9 (36.0) | 6 (24.0) | 17 (68.0) | 2 (8.0) | 25 |
Emergency contraception | 15 (41.7) | 17 (47.2) | 0 (0.0) | 0 (0.0) | 8 (22.2) | 36 | 11 (47.8) | 4 (17.4) | 11 (47.8) | 2 (8.7) | 23 |
Contraceptive patch | 10 (28.6) | 15 (42.9) | 0 (0.0) | 5 (14.3) | 8 (22.9) | 35 | 6 (26.1) | 4 (17.4) | 15 (65.2) | 3 (13.0) | 23 |
Vaginal ring | 6 (17.6) | 15 (44.1) | 0 (0.0) | 6 (17.6) | 9 (26.5) | 34 | 4 (18.2) | 2 (9.1) | 15 (68.2) | 4 (18.2) | 22 |
Self-injectable long-acting contraceptive | 5 (14.7) | 15 (44.1) | 0 (0.0) | 6 (17.6) | 10 (29.4) | 34 | 5 (22.7) | 3 (13.6) | 15 (68.2) | 4 (18.2) | 22 |
Diaphragm or cervical cap | 6 (18.2) | 13 (39.4) | 1 (3.0) | 5 (15.2) | 11 (33.3) | 33 | 5 (22.7) | 2 (9.1) | 15 (68.2) | 4 (18.2) | 22 |
Abortion self-management | 5 (14.7) | 16 (47.1) | 2 (5.9) | 3 (8.8) | 11 (32.4) | 34 | 7 (31.8) | 4 (18.2) | 15 (68.2) | 2 (9.1) | 22 |
Web-based reproductive health information | 2 (5.9) | 10 (29.4) | 14 (41.2) | 4 (11.8) | 4 (11.8) | 34 | 14 (58.3) | 2 (8.3) | 12 (50.0) | 2 (8.3) | 24 |
Reproductive health mobile phone app | 1 (2.9) | 9 (25.7) | 13 (37.1) | 8 (22.9) | 6 (17.1) | 35 | 13 (56.5) | 2 (8.7) | 8 (34.8) | 4 (17.4) | 23 |
Sexual health | |||||||||||
STI self-testing | 3 (8.8) | 15 (44.1) | 1 (2.9) | 6 (17.6) | 11 (32.4) | 34 | 6 (27.3) | 1 (4.5) | 15 (68.2) | 6 (27.3) | 22 |
HIV self-testing | 3 (8.8) | 15 (44.1) | 1 (2.9) | 6 (17.6) | 12 (35.3) | 34 | 8 (34.8) | 2 (8.7) | 15 (65.2) | 6 (26.1) | 23 |
Post-exposure prophylaxis (PEP) | 2 (6.1) | 12 (36.4) | 0 (0.0) | 10 (30.3) | 12 (36.4) | 33 | 7 (30.4) | 0 (0.0) | 15 (65.2) | 5 (21.7) | 23 |
Pre-exposure prophylaxis (PrEP) | 4 (12.1) | 14 (42.4) | 0 (0.0) | 9 (27.3) | 12 (36.4) | 33 | 6 (27.3) | 0 (0.0) | 13 (59.1) | 5 (22.7) | 22 |
HIV treatment (antiretroviral therapy) | 1 (2.9) | 16 (47.1) | 2 (5.9) | 4 (11.8) | 13 (38.2) | 34 | 7 (30.4) | 0 (0.0) | 16 (69.6) | 4 (17.4) | 23 |
STI medication treatment | 3 (8.8) | 17 (50.0) | 0 (0.0) | 5 (14.7) | 12 (35.3) | 34 | 8 (34.8) | 1 (4.3) | 1 (4.3) | 2 (8.7) | 23 |
Web-based sexual health information | 1 (2.9) | 10 (29.4) | 15 (44.1) | 4 (11.8) | 6 (17.6) | 34 | 14 (58.3) | 1 (4.2) | 13 (54.2) | 1 (4.2) | 24 |
Sexual health mobile phone app | 1 (2.9) | 9 (25.7) | 12 (34.3) | 9 (25.7) | 7 (20.0) | 35 | 13 (54.2) | 2 (8.3) | 8 (33.3) | 5 (20.8) | 24 |